Together these data indicate that MiR22 deficiency in the liver is associated with the upregulation of key factors promoting lipid uptake and glycolysis in the liver, thereby fostering the development of hepatic steatosis in obesogenic conditions. Here, MIR22 is linked to Hepatic steatosis.